USC Dornsife News

Fraser’s appointment recognizes USC’s leadership in convergent science and advances CZI’s work in science to cure, prevent or manage all diseases by the end of this century.

The USC Dornsife professor (research) of quantitative and computational biology is recognized for “distinguished and continuing achievements in original research.”

Novice surfer and director of a USC-based global collaboration to help cure diabetes joins the USC Dornsife faculty as Gabilan Assistant Professor of Chemistry. [5½ min read]

The Provost Professor of Biological Sciences, Chemistry, Neurology, Physiology and Biophysics is elected a Fellow of the American Association for the Advancement of Science. [2½ min read]

Microscape software is disrupting the scientific 3D imaging field, costing a fraction of the price of competitors’ products and able to run on home computers. [4 ¼ min read]

The findings provide a clear path to uncovering new drugs to control addiction, pain and neurological disorders such as epilepsy and muscle spasticity. [2¾ min read]

Students attribute Fulbright opportunities to study diabetes and cancer to research experience gained at the Bridge Institute at the USC Michelson Center for Convergent Bioscience.

Researchers plan to develop new sleep disorder treatments based on new 3D models of two melatonin receptors created by an international team. The studies were published in ‘Nature’ this week. [3¼ min read]

USC researchers issue a call to scientists to help them create the first comprehensive model of a cell that is central to diabetes, the pancreatic beta cell.